CBI arrests Joints Drug Controller of CDSCO, aide in bribery case

by IANS |

New Delhi, June 21 (IANS) The Central Bureau of Investigation (CBI) has said that they have apprehended a Joint Drug Controller (JDC) of Central Drugs Standard Control Organisation (CDSCO) and the Director of a private company for allegedly demanding bribe to waive the Phase-3 trial of "Insulin Aspart Injection".

The accused JDC identified as E. Eswara Reddy posted with CDSCO headquarters, New Delhi, while his aide was identified as Dinesh Dua, the Director of Delhi-based Synergy Network India Private Limited.

A senior CBI official said that a case was lodged against Reddy, Dua and others which includes Guljit Sethi, the Director of Bioinnovat Research Service Private Limited; L. Praveen Kumar, the Associate Voice President and Head of National Regulatory Affairs of Biocon Biologics Limited; Animesh Kumar, the Assistant Drug Inspector of CDSCO and others.

"It was alleged that Reddy was trying to exert undue influence on officers of CDSCO to waive the Phase-3 trial of "Insulin Aspart Injection". The accused agreed to pay bribe amount of Rs 9 lakh to Reddy for favourably processing the said three files related to Banglore-based Biocon Biologics Limited and also for favourably recommending the file of "Insulin Aspart injection" to the Subject Expert Committee meeting.

The CBI laid a trap wherein Reddy was caught while accepting a bribe of Rs 4 lakh from Dua.

The CBI also conducted searches at 11 locations in Delhi, Noida, Gurugram, Patna, Bengaluru which led to the recovery of incriminating documents.

Meanwhile, the Biocon Biologics issued a ststement saying their Aspart was approved in Europe and many other countries.

"We deny few allegations reported in India. All our product approvals are legitimate and backed by science and clinical data. Our Aspart is approved in Europe and many other countries. We follow due regulatory process for all our product approvals by DCGI. The entire application process in India is online and all meeting minutes are in public domain. We are co-operating with the investigation agency," said Biocon Biologics in a press release.

Further investigation in the matter is underway.

Latest News
'Politics of hate to hide failures': KCR hits out at Centre Mon, Aug 15, 2022, 04:49 PM
Sundar Pichai wishes India on I-Day with Google Doodle Mon, Aug 15, 2022, 03:50 PM
Marcus Stoinis faces flak for accusing Pakistan pacer Mohammad Hasnain of chucking Mon, Aug 15, 2022, 03:41 PM
UP now most preferred investment destination: Yogi Mon, Aug 15, 2022, 03:28 PM
TRS leader's murder triggers tension in T'gana's Khammam Mon, Aug 15, 2022, 03:26 PM
20 lakh jobs for Bihar youth: Nitish's I-Day announcement Mon, Aug 15, 2022, 03:23 PM
Leading cricketers wish countrymen Happy Independence Day Mon, Aug 15, 2022, 01:59 PM
2 AR troopers injured in Nagaland gunfight Mon, Aug 15, 2022, 01:50 PM
Fresh threats to Mukesh Ambani family, Mumbai cops probing Mon, Aug 15, 2022, 01:42 PM
Stoppage-time Harry Kane header earns Tottenham point at Chelsea as both managers red-carded Mon, Aug 15, 2022, 12:01 PM
Cricket Australia launches five-year strategic plan to take sport to next level Mon, Aug 15, 2022, 11:59 AM
Tesla surpasses 3 mn car production mark: Elon Musk Mon, Aug 15, 2022, 11:58 AM
Wait for 5G is over, India's 'Techade' is here: PM Modi Mon, Aug 15, 2022, 11:56 AM
Hyundai ranks 3rd in global vehicle sales in 2022 1st half Mon, Aug 15, 2022, 11:55 AM
UP to increase medicinal farming output Mon, Aug 15, 2022, 11:54 AM